Delivery Order 75F40123D00041-75F40124F19002

Award Date 2/2/24
Potential Completion Date 2/1/27
Potential Value $200K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Labor Hours
Place of Performance
Powder Springs, GA, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Realm Research LLC, a minority-owned small disadvantaged woman-owned small business, was awarded a $34,259 firm fixed price delivery order by the Department of Health and Human Services Food and Drug Administration (FDA). The order is to provide scientific and clinical support services to monitor the conduct and progress of extramural FDA-funded research studies in human subjects overseen by the Center for Drug Evaluation and Research (CDER). This delivery order is part of a larger $1.1...
The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a $308,625.00 purchase order contract to NMD Group, LLC, a woman-owned small business, to support the FDA's planning for real-world data and real-world evidence related to COVID-19. The contract has a completion date of September 7, 2021 and is structured as a labor hours contract. This contract award appears to be part of the FDA's efforts to accelerate planning and utilization of real-world data and...
The Department of Health and Human Services Food and Drug Administration awarded a $324,203.60 delivery order to Koniag Management Solutions LLC under an unspecified contract vehicle. The order is to provide two junior researchers to act as a pharmaceutical development and manufacturing specialist and as a reaction chemistry and separation specialist at the prime contractor's place of performance in Silver Spring, Maryland. The period of performance is from September 27, 2021 through...
The Department of Health and Human Services Food and Drug Administration awarded a $82,000 delivery order to Koniag Management Solutions LLC under an unspecified contract vehicle. The order is for analyst junior and researcher junior labor hours to support FDA programs in Silver Spring, Maryland, from September 2021 through September 2022. As the regulatory agency responsible for ensuring the safety and effectiveness of medical products, the FDA likely sought additional analytical resources...
The Department of Health and Human Services Food and Drug Administration awarded a $350,000 definitive cost-no-fee contract to Elligo Health Research, Inc. to support the agency's Broad Agency Announcement seeking proposals to extend the value of common data model harmonization in generating clinical evidence from real world data sufficient to support regulatory use. The small disadvantaged business will perform work at locations in Silver Spring, Maryland under the contract addressing the...
This federal contract award, with ID HHSF223201610616A, was issued by the Food and Drug Administration (FDA) to Lake Research Partners, Inc., a small disadvantaged woman-owned business. The contract, with a ceiling value of $287,814.40, is for MCM (Medical Countermeasures) studies to enhance FDA communications. The contract has a firm fixed-price structure and a completion date of February 28, 2019. The place of performance is Washington, DC. This contract award is not associated with a...
The U.S. Food and Drug Administration (FDA) awarded a new delivery order contract to IHRC, Incorporated, a small disadvantaged, woman-owned business. The $1,543,020.39 firm fixed-price contract is for office and laboratory safety workstream support services. This delivery order was issued under an existing $49.5 million FDA Indefinite Delivery/Indefinite Quantity (ID/IQ) contract that enables the agency to rapidly procure specialized technical expertise to ensure safety and compliance in its...
The Department of Health and Human Services' Food and Drug Administration (FDA) awarded a $1,275,361.26 definitive cost-no-fee contract to Alliance Nctn Foundation, a non-profit organization and foundation, to conduct the "Integrating Clinical Trials and Real World Endpoints Data (ICAREDATA) Data Capture and Standardization Study". This contract, with a performance period ending on September 29, 2024, is part of the FDA's broader efforts to advance regulatory science and support...
The U.S. Food and Drug Administration (FDA) awarded a $811,680.97 firm-fixed-price contract to Research Triangle Institute (RTI) International, a nonprofit research institute, to provide services supporting a study titled "Incorporating Women's Experiences and Prioritization of Treatment Outcomes into Regulatory Decision-Making for Medical Products." The contract has a period of performance through September 30, 2026 and was not set aside for any specific business type. RTI provides...
This is a delivery order contract awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to Ihrc, Incorporated, a self-certified small disadvantaged, woman-owned business. The contract is for a Subject Matter Expert to support the development and evaluation of microbiological methods for cosmetics. It is a firm fixed price contract with a potential value of $798,872.66 and a completion date of August 16, 2023. The contract was issued under the FDA's...
  • 75F40123D00041
    Indefinite Delivery Contract
  • 75F40123D00041-75F40124F19002
    Delivery Order

The U.S. Food and Drug Administration (FDA) awarded a $200,000 delivery order contract to Realm Research LLC, a minority-owned small disadvantaged woman-owned small business, to monitor the conduct and progress of extramural FDA-funded research studies in human subjects overseen by the Center for Drug Evaluation and Research (CDER). This contract is part of a larger $1.1 million indefinite delivery contract awarded to Realm Research in 2023 to provide broader scientific and clinical support services related to monitoring extramural CDER human subject research. The individual delivery orders do not have a set-aside designation, but the larger indefinite delivery contract was set aside for total small business participation. The contract requires performance in Georgia and Maryland with a period of performance extending to 2027, with the goal of assisting the FDA in ensuring the safety and effectiveness of human drugs by overseeing externally funded clinical trials.

Generated 6/20/24, 9:18 AM